Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2005
10/19/2005EP1586284A1 Induction of immunological tolerance
10/19/2005EP1585957A2 Magneto-optical bio-discs and systems including related methods
10/19/2005EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2005EP1585955A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/19/2005EP1585954A2 Mammalian sweet and amino acid heterodimeric taste receptors
10/19/2005EP1585811A1 Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells
10/19/2005EP1585810A1 Method for culturing cells in order to produce substances
10/19/2005EP1585805A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
10/19/2005EP1585763A2 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation
10/19/2005EP1585543A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway
10/19/2005EP1585535A2 Pthrp-derived modulators of smooth muscle proliferation
10/19/2005EP1585433A2 Detection methods
10/19/2005EP1585426A2 Cell-seeded extracellular matrix grafts
10/19/2005EP1480515B1 Inbred embryonic stem-cell derived mice
10/19/2005EP1425297A4 Isolation of neural stem cells using gangliosides and other surface markers
10/19/2005EP1373471B1 Defined culture medium
10/19/2005EP1346045B1 Human protooncogene and protein encoded therein
10/19/2005EP1307482B1 Two coloured fluorimetric protease assay
10/19/2005EP1259251B1 Novel method for down-regulation of amyloid
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005EP1088055A4 Allelic series of genomic modifications in cells
10/19/2005EP1084278B1 Detection of dna, rna and proteins
10/19/2005EP1064296B1 Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus
10/19/2005EP1015583B1 Protein containing an srcr domain
10/19/2005EP1007633B1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof
10/19/2005EP1007631B1 Cardiac muscle regeneration using mesenchymal stem cells
10/19/2005EP1002054B1 Process for the production of virus in cell cultures
10/19/2005EP0948255B1 Improved chondrogenic differentiation of human mesenchymal stem cells
10/19/2005EP0871354B1 Hypersensitive response induced resistance in plants
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685236A N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
10/19/2005CN1685234A Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
10/19/2005CN1685038A Methods for perfusion and plating of primary hepatocytes and a medium therefore
10/19/2005CN1684975A Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/19/2005CN1684974A Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
10/19/2005CN1684700A Gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/19/2005CN1684589A Vascularization enhanced graft constructs
10/19/2005CN1683525A Method for changing IL-2 receptor distribution in T cell film micro area and its use
10/19/2005CN1683524A Method for preparing nuleus embryo stem cell from somatic cell transplanting technology
10/19/2005CN1683523A Method for inducing differentiation of human peripheral blood single nucleus cell
10/19/2005CN1683522A Whole blood quality control substance as cell bio-activity protector and its preparing method
10/19/2005CN1683411A Lefteye flonder lymphocystic virus neutralizing monoclonal antibody and its preparing method
10/19/2005CN1223675C Anti tumor immunological active cell- DCIC cell, its preparing method and applications
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223604C Mycobacterium vaccae formic dehydrogenase mutant and its use
10/18/2005US6956149 Method of conveying BNYVV resistance to sugar beet plants
10/18/2005US6956117 Highly conserved non-translated regions are mutated to give rise to RNA sequence that provides greater efficiency of transduction/replication
10/18/2005US6956116 Pesticidal toxins and genes from Bacillus laterosporus strains
10/18/2005US6956113 Kits for use in monitoring and evaluating cell metabolism
10/18/2005US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses
10/18/2005US6956102 Human N-methyl-D-aspartate receptor subunits nucleic acids encoding same and uses therefor
10/18/2005US6955899 comprises collagen-like domain; tissue remodeling
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955897 Number of accessory gland proteins from Drosophila. The invention also provides an accessory gland protein which is toxic to insect cells and can be used to kill or inhibit the development of insects. Methods of controlling insects are
10/18/2005US6955894 cytokines; for increasing/decreasing signal transduction; metalloproteases; for treating inflammation during treatment of septic shock, arthritis, and/or multiple sclerosis
10/18/2005US6955884 Nucleotide sequences coding protein for use in the treatment of inflammation, graft rejection, ischemia, asthma, autoimmune disease, diabetes, arthritis, and infection
10/18/2005US6955818 for control of an external parasite on an animal of agricultural worth comprising 0.1 to 40% by weight of at least one spinosyn, and a non-irritant topically acceptable carrier, for example, tripropylene glycol methyl ether and benzyl alcohol
10/18/2005US6955809 Eye photoreceptor and pigment tissues; transplantation of tissue to subretinal area of eye; vision defect correction
10/18/2005US6955807 IL-2 selective agonists and antagonists
10/18/2005US6955802 Homeodomain protein code specifying progenitor cell identify and neuronal fate in the ventral neural tube
10/18/2005US6955625 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/18/2005CA2338820C Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression
10/13/2005WO2005095960A1 Use of a composition which regulates regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process of spermatozoa
10/13/2005WO2005095653A2 Method for collecting purified cells
10/13/2005WO2005095652A2 Pnmt as a novel marker for progenitor cells
10/13/2005WO2005095633A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
10/13/2005WO2005095632A2 Methods for identifying proteins with starch phosphorylating enzymatic activity
10/13/2005WO2005095625A1 Arabinogalactan protein compositions and methods for fostering somatic embryogenic competence
10/13/2005WO2005095623A1 Method of introducing gene in target cell
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095599A1 Novel fluorescent protein and gene encoding the same
10/13/2005WO2005095598A1 Cancer antigen peptide originating in wt1
10/13/2005WO2005095590A2 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations
10/13/2005WO2005095589A1 Pancreatic precursor cell line transdifferentiated from pancreatic acinar cell
10/13/2005WO2005095588A1 Cortex glutamatergic neuron precursor providing cortex glutamatergic neuron and cortex glutamatergic neuron precursor alone in vivo
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095586A1 Composition for cell freeze storage containing non-freezing glycoprotein derivative
10/13/2005WO2005095585A1 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture
10/13/2005WO2005095584A1 Method for expanding postembryonic stem and progenitor cells from umbilical cord blood and immunotherapeutic agent
10/13/2005WO2005095583A1 Large scale storage of viable somatic stem and/or progenitor cells
10/13/2005WO2005095582A2 Novel cell culture medium supplements
10/13/2005WO2005095581A1 Cell carrier and cell carrier containment devices containing regenerative cells
10/13/2005WO2005095578A1 Process for cell culturing by continuous perfusion and alternating tangential flow
10/13/2005WO2005095577A1 Culture container, method of culturing chondrocytes and method of evaluating chondrocytes
10/13/2005WO2005095459A2 Monoclonal antibodies to gastrin hormone
10/13/2005WO2005095458A1 CHIMERIC MONOCLONAL ANTIBODY FOR BINDING WITH HIGH AFFINITY SELECTIVELY TO hCG
10/13/2005WO2005095457A2 Immunoglobulins
10/13/2005WO2005095445A1 Novel basic antibacterial peptide and utilization thereof
10/13/2005WO2005095442A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/13/2005WO2005094914A1 Preparation of a nucleated cell and/or platelet concentrate from a physiological solution
10/13/2005WO2005094900A1 Preventive and/or remedy for cancer
10/13/2005WO2005094888A1 Damaged tissue therapeutic agent and therapeutic method
10/13/2005WO2005094887A1 sFRP EXPRESSION POTENTIATING AGENT
10/13/2005WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
10/13/2005WO2005094866A1 Adiponectin expression inducer and utilization of the same
10/13/2005WO2005094852A2 Sperm suspensions for use in insemination
10/13/2005WO2005094846A1 Remedy for prion disease and method of producing the same